Vaccinex Net Debt Growth & History (VCNX)
Vaccinex's net debt was −$1.1M for fiscal 2024.
View full Vaccinex company overviewVaccinex annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | −$1.1M | $206,236 | — |
| 2023 | 2023-12-31 | −$1.3M | $4.6M | — |
| 2022 | 2022-12-31 | −$5.9M | $2.3M | — |
| 2021 | 2021-12-31 | −$8.2M | $1.3M | — |
| 2020 | 2020-12-31 | −$9.5M | — | — |
Vaccinex quarterly net debt
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | −$1.1M | $206,236 | — |
| Q3 2024 | 2024-09-30 | −$2.8M | −$3.0M | — |
| Q2 2024 | 2024-06-30 | −$110,675 | $1.4M | — |
| Q1 2024 | 2024-03-31 | −$2.8M | $109,025 | — |
| Q4 2023 | 2023-12-31 | −$1.3M | $4.6M | — |
| Q3 2023 | 2023-09-30 | $179,866 | $6.8M | — |
| Q2 2023 | 2023-06-30 | −$1.5M | $9.6M | — |
| Q1 2023 | 2023-03-31 | −$2.9M | $13.6M | — |
| Q4 2022 | 2022-12-31 | −$5.9M | $2.3M | — |
| Q3 2022 | 2022-09-30 | −$6.6M | $5.8M | — |
| Q2 2022 | 2022-06-30 | −$11.1M | $9.9M | — |
| Q1 2022 | 2022-03-31 | −$16.5M | $11.8M | — |
| Q4 2021 | 2021-12-31 | −$8.2M | $1.3M | — |
| Q3 2021 | 2021-09-30 | −$12.4M | $3.5M | — |
| Q2 2021 | 2021-06-30 | −$21.0M | −$21.6M | — |
| Q1 2021 | 2021-03-31 | −$28.3M | — | — |
| Q4 2020 | 2020-12-31 | −$9.5M | — | — |
| Q3 2020 | 2020-09-30 | −$16.0M | — | — |
| Q2 2020 | 2020-06-30 | $608,000 | — | — |
| Q2 2018 | 2018-06-30 | −$21,000 | — | — |
Vaccinex net debt trends
Between the periods ended 2020-12-31 and 2024-12-31, Vaccinex's net debt increased from −$9.5M to −$1.1M, a change of $8.4M. The latest reported quarter, Q4 2024, shows −$1.1M.
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vaccinex source filings ↗